Patients and methods 
addition, to determine the contribution of non-specific uptake of [18F] F-DA in the myocardium in patients with recent heart transplant.
Protocol- [18F] F was prepared by direct electrophilic fluorination of dopamine. Nine healthy volunteers each received 1-85 x 108 Bq (168-250pg) [18F1F-DA over a period of 3 min and were scanned for 2 h in an ECAT 953131 tomograph. Three controls were scanned before and after vigorous cycle exercise and two were scanned before and after sublingual glyceryl trinitrate. In addition, two patients (1 and 2 years post-heart transplant) underwent a myocardial perfusion study with ammonia labelled with nitrogen-13 followed by an [18F] F-DA study.
Results-There was intense uniform uptake of [18F] F-DA throughout the myocardium in the healthy volunteers. The time course of 18F in the myocardium under resting conditions fitted a biexponential function with mean half-times of 8-0 and 109 min. Vigorous exercise produced a three to fivefold increase in the rate of loss of 18F compared with that when resting. After glyceryl trinitrate, one control had a profound reduction in blood pressure (23%) and twofold increase in the rate of loss of myocardial "8F. The other control had no physiologically significant change in blood pressure, heart rate, or rate of loss of myocardial 18F . Uptake of [18F] F-DA in the two posttransplant patients was confined to a small anterobasal region adjacent to the atrioventricular groove, while blood flow, as measured with [13N] ammonia, was uniformly distributed throughout the myocardium. Partial reinnervation of the myocardium was confirmed by the presence of distinct low frequency spectral peaks of the heart rate power spectrum in both patients. Conclusions-These results suggest that the uptake of [18F] A mixture of 18F labelled 2 and 6-fluorodopamine was prepared by direct fluorination of dopamine in anhydrous hydrogen fluoride containing boron trifluoride.5 [18F]F-DA was separated from the reaction mixture by reverse phase high performance liquid chromatography (HPLC) (5 p particle Vydac C-1 8 semipreparative column) using 0 1% trifluoroacetic acid in water containing 4-5% acetonitrile as the mobile phase with a flow rate of 1 ml/min. The final compound was characterised by its molecular ions using high resolution mass spectrometry and by hydrogen-1, carbon-13, and fluorine-19 nuclear magnetic resonance spectrometry. After isolation of the final product, it was evaporated to dryness, reconstituted in physiological saline, and sterilised by filtration through a 0-2 pm The scanner used in these experiments was an ECAT 953/31 tomograph that examines simultaneously 31 transaxial sections. The spatial resolution of the tomograph is 5 mm in all directions. Correction for attenuation is done using a rod source containing germanium-68/gallium-68 that can be extended into the field of view. With the rod source extended, an axial scan of the chest was performed before each study to identify the heart and centre it in the field of view.
UPTFAKE AND WASH-OUT OF FLUORINE-18
In each study, we positioned the participant with the heart in the field of view of the positron emission tomography (PET) scanner and obtained a 30 min transmission scan for attenuation correction. We then infused 1.85 x 108 Bq (168-250pug) [18F] F-DA in 10 ml saline over a period of 3 min. This was equivalent to 10-1-8 pg/kg/min. Dynamic images were collected at a frame rate of 10 s/frame for 12 frames, 30s/frame for six frames, and either 150 or 300 s/frame for the remainder of the study for a total scanning time of 2 h. The following protocols were followed. Firstly, nine healthy controls (aged were studied at rest for 2 h after ['8F]F-DA injection.
Secondly, to determine whether the decline of '8F in the myocardium was linked to NA turnover, we examined the effect of exercise.
Three controls were studied at rest for 1 h. They then left the PET scanner and exercised on a bicycle ergometer for 30 min at approximately 60% of maximum predicted power output. After exercise they were repositioned in the PET scanner and the dynamic data were collected for a fujrther 1 h. Correct repositioning was confirmed with a laser beam system.
Thirdly, two of the volunteers were studied at rest for 1 h. Each was then given sublingual glyceryl trinitrate and data were collected for a further 1 h. The purpose of using glyceryl trinitrate was to elicit reflex cardiac sympathetic activation without a concomitant increase in myocardial blood flow.7 Control 1 received 1-8 mg glyceryl trinitrate sublingually over 20 min and control no 2 received 0-6 mg glyceryl trinitrate sublingually. Blood pressure, pulse, and electrocardiogram (ECG) were monitored continuously for 5 min before glyceryl trinitrate and then every 3-5 min to the end of the study. Blood samples for plasma NA were taken at 5 min intervals starting immediately before administration of glyceryl trinitrate.
Fourthly, two patients who received orthotropic heart transplants 14 and 27 months earlier were studied at rest for 2 h. This was done to determine non-specific [ The time course of '8F radioactivity from an annular region of interest in the myocardium halfway between the apex and base was fitted to the sum of two exponentials using non-linear least squares optimisation.'0
The counts at each time point were normalised to the injected dose.
Results
There were no changes in pulse rate, blood pressure, or ECG in any participant during 
The decline of '8F in the myocardium in the resting controls (study 1) was best fitted by two decaying exponential curves (fig 2(A) ). The mean (range) half-time of the fast component in these controls had a half-time of 8-0 (5A4-8 8) min. The slow component had a mean (range) half-time of 109 (78-146) min.
Exercise caused the heart rate to increase from 60-70 to 135-150 beats per minute (study 2). There was a three to fivefold reduction in myocardial radioactivity concentration after the exercise period (fig 2(B) ).
In control 2 0-6 mg of sublingual glyceryl trinitrate caused a profound decrease in systolic blood pressure from a mean of 111 mm Hg before glyceryl trinitrate to a low of 85 mm Hg systolic 9 min after administration (study 3). Systolic pressure returned to pre-glyceryl nitrate levels after 27 min. There was a statistically significant increase in the low frequency (sympathetic) component of the power spectrum of heart rate variability and a decrese in the high frequency (vagal) component (fig 3) starting 6 min after administration of glyceryl trinitrate. Plasma NA increased from 2-53 nmol/l before to 4-48 nmol/l 5 min after glyceryl trinitrate (the last sample taken). During the hypotensive period after glyceryl trinitrate the rate of decline in radioactivity concentration of '8F in the myocardium doubled.
In control 1 there was only a transient reduction in systolic pressure from 120 to 109 mm Hg after the third 0-6 mg tablet of glyceryl trinitrate. There was no change in the Freauencv (Hz) Figure 3 Power spectral plotfrom control no 2 before and after sublingual glyceryl trinitrate (GTN) (0-6 mg). Note a significant increase in the low frequency (sympathetic) component and a decrease in the high frequency (vagal) component with GTN. ratio of low/high frequency peaks in the power spectrum of heart rate variability and no change in the rate of decline in 18F.
In both heart transplant patients (study 4) there was a uniform distribution of ["IN] ammonia in the myocardium reflecting a uniform blood flow to the myocardium (fig 4) . In contrast, uptake of ['8F]F-DA was limited to a small region of the anterobasal myocardium subjacent to the atrioventicular groove (fig 4) . Uptake in the rest of the myocardium was negligible and indistinguishable from background lung activity.
Discussion
We have demonstrated intense and uniform uptake of ['8F]F-DA in the myocardium of normal healthy volunteers under resting supine conditions. As in previous experiments in animals'4" and humans, our findings in humans suggest that there is specific retention of [18F]F-DA by sympathetic neurones. Only minimal uptake was seen in the partially denervated heart and this finding was supported by partial sympathetic reinnervation seen on the power spectrum of heart rate variability.
The rate of wash-out of 18F from the myocardium was increased in response to increased cardiac sympathetic activity as induced by exercise or sublingual glyceryl trinitrate. This increased wash-out of '8F could be due to increased turnover in, and spill over of, NA labelled with "8F(["8F]F-NA) formed from [18F] F-DA in the cardiac sympthetic neurones.
Experiments in animals have established that after intravenous injection fluorodopamine behaves like endogenous dopamine in the heart. It is transported into sympathetic neurones, converted by dopamine fi hydroxylase to fluoronoradrenaline and stored in sympathetic storage vesicles."'2-4 After intravenous injection of 6-fluorodopamine labelled with 3H into rats, 40% of the 3H in the heart after 1 h was in the form of [3H] 6-fluoronoradrenaline."3 Eisenhofer et al"3 also reported that, after correction for injected dose, the tissue content of [3H] 6-fluoronoradrenaline in the rat heart, although less than after dopamine, labelled with 3H, was greater than with 2-fluorodopamine labelled with 3H. For this reason, we have used 6-fluoro isomer of [18F] F-DA. In normal volunteers Goldstein et a14 reported a 50% reduction in myocardial uptake of [18F] F-DA following blockage of neuronal uptake of catecholamines with desipramine. In addition, urinary excretion of vanillomandelic acid labelled with 18F at position 6 was demonstrated. This provided the first direct evidence in humans for the specific neuronal uptake of [18F]F-DA, its translocation into vesicles and conversion to [18F] F-NA.
Stimulation of the cardiac sympathetic system in animals by either application of electrodes to the stellate ganglia"5 or reducing blood pressure16 causes release ofNA from presynaptic storage vesicles. Most of this undergoes active reuptake by presynaptic neurones but some "spills" into the surrounding extracellular fluid and appears in venous blood. ' 2 Sympathetic stimulation also causes release of stored fluoronoradrenaline from the hearts of intact animals. Chang et al'4 demonstrated release of stored [3H] 6-fluoronoradrenaline after increasing sympathetic nerve activity by injecting the a 2-adrenoreceptor blocker yohimbine. In this same study'4 they also recovered the expected metabolites of 6-fluorodopamine labelled with 3H in plasma, namely 6-fluorohomovanillic acid and 6-fluoro-3, 4-dihydroxyphenylacetic acid. Goldstein et al3 demonstrated in dogs that the rate of decline of 18F in the myocardium after [18F] F-DA increased when the sympathetic system was activated by nitroprusside.
These experiments in animals and humans and our own data in humans suggest that at least some of the injected [18F] The increased wash out of 18F from the myocardium during exercise could be secondary to increased myocardial blood flow or increased plasma NA during exercise competing for reuptake with the [18F] F-NA that has been formed from [18F] F-DA. The results of the glyceryl trinitrate experiments, however, suggest that neither of these events caused the increased 18F wash-out during exercise. Plasma NA concentration doubled in both controls after glyceryl trinitrate administration as would be expected in untrained individuals during exercise'7 but 18F wash-out increased in only one participant. The increased rate of 18F wash-out in control 2 after administration of glyceryl trinitrate is unlikely to be secondary to increased myocardial blood flow because this drug does not cause a global or regional increase in blood flow to the healthy myocardium.7 It does, however, stimulate NA release from prejunctional neurones as a result of a reflex hypotensive response.
It is likely, then, that the increased wash-out rate of 18F from the myocardium during exercise in the three controls and after glyceryl trinitrate in one healthy volunteer was due to increased cardiac sympathetic activity.
In the two patients with recent heart trans- 
